Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gene Biotherapeutics, Inc. (CRXM) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gene Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 772320.
Total stock buying since 2021: $92,400.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 500,000 | $92,400 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-03 | 500,000 | $92,400 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-17 | Jemapete Christopher J | Buy | 200,000 | .40 | 80,400 |
| 2021-03-16 | Jemapete Christopher J | Buy | 300,000 | .04 | 12,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRXM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gene Biotherapeutics, Inc. (symbol CRXM, CIK number 772320) see the Securities and Exchange Commission (SEC) website.